United Therapeutics (UTHR) Treasury Shares (2009 - 2026)

United Therapeutics has disclosed Treasury Shares across 18 years of filings, most recently posting $5.6 billion for Q2 2026.

• In Q2 2026, Treasury Shares rose 62.47% year-over-year to $5.6 billion; the TTM figure through Jun 2026 stood at $5.6 billion (up 62.47% YoY), while the FY2025 annual figure was $4.3 billion, up 22.62% from the prior year.
• Treasury Shares came in at $5.6 billion for Q2 2026 at United Therapeutics, up from $5.4 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $35.4 million in Q2 2026 to a low of $26.6 million in Q1 2022.
• Average Treasury Shares over 5 years is $29.4 million, with a median of $30.0 million recorded in 2024.
• Year-over-year, Treasury Shares changed 0.0% in 2022 and surged 62.47% in 2026.
• Over 5 years, Treasury Shares stood at $2.6 billion in 2022, then changed by 0.0% to $2.6 billion in 2023, then surged by 34.71% to $3.5 billion in 2024, then climbed by 22.62% to $4.3 billion in 2025, then soared by 32.5% to $5.6 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $5.6 billion in Q2 2026, $5.4 billion in Q1 2026, and $4.3 billion in Q4 2025.